receptors on platelet membrane 6 . Compared to clopidogrel and prasugrel, ticagrelor inhibit adenosine diphosphate (ADP) induced platelet aggregation more rapidly and more consistently to a greater extent both in the healthy subjects and in patients with coronary artery disease including those undergoing percutaneous coronary intervention (PCI) 7 and reduce the risk of death either resulting from vascular cause, myocardial infraction (MI) or stroke 8 . For this reversible binding of ticagrelor to ADP-receptors, the post percutaneous bleeding tendency in CSA patients would expectedly be lower than that in patients receiving clopidogrel 9 .
In patients of ACS following PCI, the chance of thrombotic phenomenon is increased because of oxidative injury .In that situation an antiplatelet drug having anti-oxidative property could be a better option. Therefore the present study has been designed to compare the anti-oxidative properties of ticagrelor and clopidogrel in CSA patients following PCI.
Materials and Methods:
The present prospective observational study was carried out in the Department of Pharmacology, Cardiology and Microbiology, BSMMU, Dhaka from September 2014 to February 2016. Patients who were to suffer from as a case of chronic stable angina and under-going PCI in cardiology department of BSMMU and also fulfilled theexclusion criteria were the study population. 
Estimation of erythrocyte glutathione (GSH) level by Ellman's method 11
The simple spectrophotometric procedure for GSH estimation is based on the method of Ellman, who reported that 5, 5-dithiobis-2-nitrobenzoic acid is reduced by SH group to form 1 mole of 2-nitro-5-mercaptobenzoic acid per mole of (-SH). The nitromercaptobenzoic acid anion has an intense yellow color and can be used to measure SH groups. The optimal condition for color development and preparation of homogenates has been studied with respect to precision, reducibility and specificity of the estimation17. This color intensity was measured by the spectrophotometer (UV-VIS spectrophotometer) at 412 nm wavelength.
Result:
The present study aimed at comparing the effect of Ticagrelor and Clopidogrel on oxidative stress markers in patients of chronic stable angina (CSA) following PCI. The baseline laboratory parameters (MDA, GSH, bleeding time, clotting time and platelet count) were measured and then both groups underwent PCI. The same parameters were again assessed at follow up after 4 weeks of PCI discharged with ticagrelor and clopidogrel. Total 12 patients from Ticagrelor and 14 patients from Clopidogrel groups dropped out leaving 38 in the former and 36 in the latter group for final analysis. Comparisons of the laboratory parameters were made between groups both at baseline and at follow up and within group before and after intervention. The findings of the study derived from data analyses are presented below: Table-shows the distribution of baseline characteristics  between Ticagrelor and Clopidogrel groups There was no significant difference between the groups in terms of age with mean age of the patients being around 50 years (p = 0.322). The sex distribution was identical with male predominance in either group (p = 0.328). About one-quarter (22.5%) of the Ticagrelor group and one-third (32.5%) of the Clopidogrel group were diabetic (p = 0.201).
Baseline characteristics
Over two-thirds (70%) of the former and 65% of the latter group had hypertension with no significant intergroup difference (p = 0.208). 
Baseline characteristics ofTicagrerol and Clopidogrel groups

Lab findings of MDA level in both groups at baseline and follow up
The mean plasma MDA levels of Ticagrelor and Clopidogrel groups were almost similar (4.5 ± 1.8 ¼mol/L vs. 4.2 ± 1.2 ¼mol/L, p = 0.306). The level of plasma MDA in both Ticagrelor and Clopidogrel groups were decreased at follow up 4 weeks after PCI (1.4 ± 0.7 vs. 1.3 ± 0.7, ¼mol/ L P = 0.580). Data were analyzed using unpaired t-Test and were presented as mean ± SD
Lab findings of erythrocyte GSHlevel in both groups at baseline and follow up
The erythrocyte GSH was also identically distributed between groups (p = 0.958).The level of GSH was increased in both groups with increase being significantly more in ticagrerol group than clopidogrel (2.5± 0.9 vs. 1.4 ± 0.8 mg/ gm of Hb, p < 0.001). Data were analyzed using unpaired tTest and were presented as mean ± SD 
Percentage of changes in oxidative stress markers (GSH and MDA) in Ticagrerol and
Discussion
Coronary artery disease (CAD) is the major cause of mortality and morbidity worldwide 12, 13 .Blockade of blood flow inside the coronary arteries or narrowing of the arterial lumina due to atherosclerotic changes are the primary factors leading to CAD. Free radicals are formed in both physiological and pathological conditions in mammalian tissues including cardiac tissues 14 . Alteration in the oxidant-antioxidant profile may occur in many diseases including CAD. If not nullified by endogenous antioxidants of the body or if endogenous anti-oxidant become depleted due to any cause, uncontrolled elevation of free radicals may occur and may lead to tissue damage or tissue necrosis. Previous studies have suggested that oxidative stress may be involved in CAD and that higher production of free radical production and decreased anti-oxidant activity are indicative of oxidative stress in CAD 3 .
In the present study two PCI groups receiving ticagrelor and clopidogrel along with aspirin were taken for comparison between the outcomes of either drug administration following PCI. The objective was to assess whether clopidogrel or ticagrerol would provide better results if administered in CAD patients following PCI. The patients groups taken were almost identical in terms of their demographic characteristics (age and sex). Disease conditions such as diabetes and hypertension were equally distributed between the groups. The parameters to be measured in the present study such as MDA, erythrocyte GSH, platelet count, bleeding time and clotting time when obtained prior to drug administration appeared similarly distributed between the treatment groups. Thus as most of the baseline characteristics were similar in distribution between the comparative groups, the outcome obtained could be assumed to be due to intervention by the administered drugs.
The oxidant-antioxidant markers the MDA (product of lipid peroxidation indicative of oxidant stress) levels were high in either ticagrerol or clopidogrel group prior to intervention by the drugs. This finding is in accordance with that of 12 , who have stated that patients of CAD show increased oxidative stress. Stressful conditions lead to oxidant-antioxidant imbalance and higher lipid peroxidation. The higher the lipid peroxidation, the higher becomes the level of MDA in tissues. After ticagrerol or clopidogrel administration, both groups demonstrated reduced levels of MDA. This would suggest that the process of lipid peroxidation was reduced following clopidogrel and ticagrerol administration, as a result of reduced oxidative stress. The pattern of reduction of MDA levels were similar in both groups. A reason might be that the MDA values obtained from both groups prior to drug administration were of similar pattern perhaps due to identical demographic characters and, perhaps the identical demographic characteristic of both drug-treated groups were responsible for these findings. However, results of the present study indicate that both ticagrerol and clopidogrel were almost equal effective in exerting anti-lipid peroxidation effect. These observations of the present study resemble to those of 3, 12 .
The reduced glutathione (GSH) levels in RBC membranes of both groups before drug administration were lower (0.7 ± 0.3 in ticagrerol group and 0.6 ± 0.2 in clopidogrel group). This would suggest that glutathione levels become depleted in CAD patients perhaps due to oxidants produced as a result of stress and are similar findings 12 .
We propose that the decreased levels of the anti-oxidants may be a compensatory regulation in response to increased oxidative stress as has also been suggested 3 . Significant elevations have occurred in GSH levels in both groups following treatment by either clopidogrel or ticagrerol after 4 weeks of administration of the drugs (2.5 ± 0.9 in ticagrerol group and to 1.4 ± 0.8 in the clopidogrel group, p <0.001). This would suggest that administration of both drugs in either group could replenish the GSH levels. This finding is similar 3 ,12 and support their findings that the levels of antioxidant enzymes remains lower in CAD patients, which may become replenished when recovery occurs. In the present study, the replenishment of GSH was more evident in the ticagrerol treated group of patients, suggesting that the anti-oxidant and glutathione replenishing efficacy of ticagrerol was more obvious compared to that of clopidogrel. 
